Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Jul;34(7):1453–1455. doi: 10.1128/aac.34.7.1453

In vitro susceptibilities of oxacillin-resistant Staphylococcus aureus to dapsone and sulfamethoxazole alone and in combination with trimethoprim.

M W Lambertus 1, R Y Kwok 1, M E Mulligan 1
PMCID: PMC176001  PMID: 2117420

Abstract

The in vitro activity of trimethoprim plus dapsone against oxacillin-resistant Staphylococcus aureus was comparable to that of trimethoprim plus sulfamethoxazole. Because of its different pharmacologic properties, dapsone may be a useful agent in combination with trimethoprim for the treatment of patients colonized with oxacillin-resistant S. aureus.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHATTERJEE K. R., PODDAR R. K. Preferential uptake of sulphone by affected skin tissue of leprosy patients as detected by a tracer method. Nature. 1956 Oct 13;178(4537):799–800. doi: 10.1038/178799b0. [DOI] [PubMed] [Google Scholar]
  2. DeGowin R. L. A review of therapeutic and hemolytic effects of dapsone. Arch Intern Med. 1967 Aug;120(2):242–248. [PubMed] [Google Scholar]
  3. Grunberg E., Beskid G. Studies on the in vitro development of drug resistance of Proteeae to sulfonamides, trimethoprim and combinations of a sulfonamide and trimethoprim. Chemotherapy. 1977;23(5):309–313. doi: 10.1159/000222000. [DOI] [PubMed] [Google Scholar]
  4. Haley R. W., Hightower A. W., Khabbaz R. F., Thornsberry C., Martone W. J., Allen J. R., Hughes J. M. The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med. 1982 Sep;97(3):297–308. doi: 10.7326/0003-4819-97-3-297. [DOI] [PubMed] [Google Scholar]
  5. Wormser G. P., Keusch G. T., Heel R. C. Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy. Drugs. 1982 Dec;24(6):459–518. doi: 10.2165/00003495-198224060-00002. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES